Recognizing unusual manifestations of hodgkin lymphoma

Nicholas A. Barber, Philip Jay Bierman

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

Hodgkin lymphoma (HL) is a rare malignancy of the lymphatic system that is curable in at least 80 % of patients. Although patients usually present with painless lymphadenopathy, a variety of systemic and organ-specific syndromes may also exist in relation to HL. These syndromes may develop before, during, or after the diagnosis of HL and may also indicate disease relapse. Most of these unusual disorders resolve with successful HL treatment but some may require adjunctive supportive therapies before a response is achieved. Oncologists should be familiar with these syndromes because early recognition may result in a more timely diagnosis of HL which may lead to improved outcomes.

Original languageEnglish (US)
Pages (from-to)186-192
Number of pages7
JournalCurrent Hematologic Malignancy Reports
Volume7
Issue number3
DOIs
StatePublished - Sep 1 2012

Fingerprint

Hodgkin Disease
Lymphatic System
Recurrence
Therapeutics
Neoplasms

Keywords

  • Cholestasis
  • Constitutional B-symptoms
  • Cutaneous
  • Cytokines
  • Cytopenias
  • Encephalitis
  • Glomerulonephropathy
  • Hodgkin lymphoma
  • Paraneoplastic

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Recognizing unusual manifestations of hodgkin lymphoma. / Barber, Nicholas A.; Bierman, Philip Jay.

In: Current Hematologic Malignancy Reports, Vol. 7, No. 3, 01.09.2012, p. 186-192.

Research output: Contribution to journalReview article

@article{965738ba0f9648279d114e4f31a2755a,
title = "Recognizing unusual manifestations of hodgkin lymphoma",
abstract = "Hodgkin lymphoma (HL) is a rare malignancy of the lymphatic system that is curable in at least 80 {\%} of patients. Although patients usually present with painless lymphadenopathy, a variety of systemic and organ-specific syndromes may also exist in relation to HL. These syndromes may develop before, during, or after the diagnosis of HL and may also indicate disease relapse. Most of these unusual disorders resolve with successful HL treatment but some may require adjunctive supportive therapies before a response is achieved. Oncologists should be familiar with these syndromes because early recognition may result in a more timely diagnosis of HL which may lead to improved outcomes.",
keywords = "Cholestasis, Constitutional B-symptoms, Cutaneous, Cytokines, Cytopenias, Encephalitis, Glomerulonephropathy, Hodgkin lymphoma, Paraneoplastic",
author = "Barber, {Nicholas A.} and Bierman, {Philip Jay}",
year = "2012",
month = "9",
day = "1",
doi = "10.1007/s11899-012-0131-4",
language = "English (US)",
volume = "7",
pages = "186--192",
journal = "Current Hematologic Malignancy Reports",
issn = "1558-8211",
publisher = "Springer Science + Business Media",
number = "3",

}

TY - JOUR

T1 - Recognizing unusual manifestations of hodgkin lymphoma

AU - Barber, Nicholas A.

AU - Bierman, Philip Jay

PY - 2012/9/1

Y1 - 2012/9/1

N2 - Hodgkin lymphoma (HL) is a rare malignancy of the lymphatic system that is curable in at least 80 % of patients. Although patients usually present with painless lymphadenopathy, a variety of systemic and organ-specific syndromes may also exist in relation to HL. These syndromes may develop before, during, or after the diagnosis of HL and may also indicate disease relapse. Most of these unusual disorders resolve with successful HL treatment but some may require adjunctive supportive therapies before a response is achieved. Oncologists should be familiar with these syndromes because early recognition may result in a more timely diagnosis of HL which may lead to improved outcomes.

AB - Hodgkin lymphoma (HL) is a rare malignancy of the lymphatic system that is curable in at least 80 % of patients. Although patients usually present with painless lymphadenopathy, a variety of systemic and organ-specific syndromes may also exist in relation to HL. These syndromes may develop before, during, or after the diagnosis of HL and may also indicate disease relapse. Most of these unusual disorders resolve with successful HL treatment but some may require adjunctive supportive therapies before a response is achieved. Oncologists should be familiar with these syndromes because early recognition may result in a more timely diagnosis of HL which may lead to improved outcomes.

KW - Cholestasis

KW - Constitutional B-symptoms

KW - Cutaneous

KW - Cytokines

KW - Cytopenias

KW - Encephalitis

KW - Glomerulonephropathy

KW - Hodgkin lymphoma

KW - Paraneoplastic

UR - http://www.scopus.com/inward/record.url?scp=84865995143&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865995143&partnerID=8YFLogxK

U2 - 10.1007/s11899-012-0131-4

DO - 10.1007/s11899-012-0131-4

M3 - Review article

VL - 7

SP - 186

EP - 192

JO - Current Hematologic Malignancy Reports

JF - Current Hematologic Malignancy Reports

SN - 1558-8211

IS - 3

ER -